L-Arginine.

Citrulline is converted back to arginine in the kidneys, and because it bypasses first-pass gut and liver breakdown it raises circulating arginine more steadily than arginine taken alone. The two feed the same nitric oxide pathway that supports normal blood vessel tone.

Arginine supports nitric oxide through the enzyme-driven NOS route, while dietary nitrate supports it through the separate nitrate to nitrite to nitric oxide route that stays active in low-oxygen tissue. Because they reach the same end molecule by different mechanisms, they are often formulated together to support normal blood vessel tone.

Pine bark polyphenols help keep the endothelial NOS enzyme active, and arginine is the raw substrate that enzyme uses to make nitric oxide. Pairing the enzyme support with its fuel is why the two are commonly formulated together for normal endothelial function.

Arginase hydrolyses L-arginine into ornithine and urea, and ornithine feeds back through citrulline to arginine. The pair sits on adjacent steps of the same cycle.

Agmatine is formed when arginine is decarboxylated, and it then modulates nitric oxide synthase and arginase activity. Substrate and metabolite act at different points.

Lysine and arginine share the y+ cationic amino acid transporters, so a high lysine dose competes for intestinal and renal uptake of arginine. Separating the doses avoids that.

Norvaline inhibits arginase, the enzyme that diverts arginine into urea, so more arginine stays available to nitric oxide synthase.

Arginine and glycine form guanidinoacetate, the immediate precursor methylated into creatine. Supplying creatine directly reduces the arginine pulled into that route.

Arginine and glycine are the two substrates of arginine glycine amidinotransferase, the enzyme that makes guanidinoacetate on the way to creatine. Neither works at that step without the other.

Ascorbate helps keep tetrahydrobiopterin reduced so nitric oxide synthase stays coupled, and it scavenges superoxide that would otherwise consume the nitric oxide arginine yields.

Converting guanidinoacetate into creatine spends a methyl group from S-adenosylmethionine, and betaine remethylates homocysteine to restore that pool. It keeps the arginine-fed step supplied.

Enterocytes turn glutamine into citrulline through glutamate and ornithine, and the kidney converts that citrulline into arginine. Glutamine feeds the endogenous arginine route.

Citrulline escapes intestinal arginase and is converted to arginine in the kidney, so it lifts plasma arginine efficiently while the malate feeds the citric acid cycle.

Beetroot nitrate is reduced by oral bacteria and tissue enzymes to nitrite and then nitric oxide, a route that does not need nitric oxide synthase. It runs alongside the arginine pathway.

Folate supports regeneration of tetrahydrobiopterin, the cofactor nitric oxide synthase needs to convert arginine productively rather than uncoupling.

Nitric oxide synthase is a flavoprotein that carries both FAD and FMN in its reductase domain, and riboflavin is the dietary source of both. Electron transfer from NADPH to the heme domain, where arginine is converted, runs through those flavins. This is cofactor biochemistry rather than a tested combination, so read it as mechanistic.

Niacin supplies the nicotinamide ring of NADP, and NADPH is the reducing equivalent consumed when arginine is hydroxylated and then cleaved to nitric oxide and citrulline. Without NADPH the reaction does not turn over. The relationship is settled biochemistry, not a clinical claim about either ingredient.

Each nitric oxide synthase monomer carries a heme prosthetic group at the site where arginine binds, and heme synthesis depends on iron. Iron status therefore sits upstream of the whole arginine to nitric oxide step. This is a cofactor relationship and says nothing about supplementing iron for that purpose.

A rise in intracellular calcium loads calmodulin, and calmodulin binding is what couples the reductase and oxygenase domains so electrons reach the heme. Arginine availability matters only once that activation step has happened. The pairing is mechanistic and describes normal enzyme regulation.

Arginase holds two manganese ions in its active site and splits arginine into ornithine and urea, the competing branch to nitric oxide synthase. Manganese therefore supports the route that draws arginine away from nitric oxide production. Listing it as modulating rather than additive is the honest direction.

Arginine gives its amidino group to glycine to form guanidinoacetate, and the final step methylates that intermediate. The methyl comes from S-adenosylmethionine, which is made from methionine. Methionine supply therefore sits on the same two-step route as arginine.

The creatine route starts with arginine and glycine and finishes when S-adenosylmethionine methylates guanidinoacetate. It is one of the larger consumers of labile methyl groups in the body. The link is textbook and is about a shared pathway, not a tested product combination.

5-methyltetrahydrofolate hands a methyl group to homocysteine to remake methionine, which is then reactivated as S-adenosylmethionine. Heavy demand from guanidinoacetate methylation pulls on that cycle. This is a pathway relationship measured in metabolites, which are markers rather than outcomes.

Methionine synthase needs a cobalamin cofactor to move the folate methyl group onto homocysteine. That step reloads the methyl donor spent when guanidinoacetate becomes creatine. It is a cofactor link in one-carbon metabolism and is described here as mechanism only.

Nitric oxide synthase needs reduced tetrahydrobiopterin to stay coupled; when that cofactor oxidises the enzyme makes superoxide instead. Cysteine supply feeds glutathione, which participates in keeping the cellular redox environment reducing. The connection is mechanistic and has not been settled in combination trials.

Glutathione is the main intracellular redox buffer and helps limit oxidation of tetrahydrobiopterin, the cofactor that keeps the arginine reaction coupled. Coupling determines whether the enzyme yields nitric oxide or superoxide. Read this as mechanism rather than a demonstrated combined effect.

Ubiquinol participates in mitochondrial and membrane redox handling in endothelial cells, the same cells where arginine is converted to nitric oxide. Both are often studied against vascular function markers. Markers are not outcomes, and the two have not been jointly characterised well enough to claim more.

EPA and DHA incorporate into endothelial membranes and are studied against flow-mediated dilation and related vascular markers, the same readouts used for arginine work. The routes differ, so any combined effect would be additive rather than synergistic. These are markers of vessel behaviour, not clinical endpoints.

Magnesium influences vascular smooth muscle tone through calcium handling, while arginine acts upstream of nitric oxide. Taken together the directional effect on blood pressure readings would stack rather than cancel. Anyone monitoring blood pressure should account for the pairing rather than assume the effects are independent.

Potassium intake affects sodium handling and vascular tone, a separate route from nitric oxide production. Combined use points the same direction on blood pressure numbers. The point of flagging it is additivity, not a claim that either lowers pressure in a given person.

Garlic preparations carry organosulfur compounds studied for effects on vascular tone and platelet behaviour. Arginine works through the nitric oxide route. The two are frequently combined in cardiovascular formulas, and the additive direction on blood pressure readings is the reason to note it.

Taurine is studied for effects on endothelial function and vascular tone through routes distinct from nitric oxide synthase. The two appear together in pre-workout and cardiovascular formulas. Evidence for the combination specifically is thin, so this stays at the mechanistic level.

Alpha-lipoic acid cycles between oxidised and reduced forms and participates in regenerating other antioxidants. That redox environment influences whether the nitric oxide synthase cofactor stays reduced. The link is indirect and early, and it is offered as mechanism only.

Grape seed proanthocyanidins are studied for effects on endothelial nitric oxide signalling, which is downstream of the substrate arginine supplies. The pairing is common in vascular formulas. The supporting work is largely mechanistic and in vitro, so the confidence stays low.

Many gut bacteria carry arginase and arginine deiminase and will consume free arginine in the lumen, which is one reason oral arginine reaches plasma less efficiently than citrulline. Changing the microbial community can change how much survives to the enterocyte. The direction of that change is not predictable from current work.